Publication Date
1-4-2023
Journal
Cancer Prevention Research
Abstract
Bexarotene is a rexinoid that has been shown to prevent mammary tumors in mouse models but oral dosing has toxicities. This phase I study evaluates topical bexarotene, as a potential chemoprevention agent, for safety and toxicity in high-risk women for breast cancer.
Keywords
Female, Bexarotene, Neoplasms, Humans, Administration, Topical, Antineoplastic Agents
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Community Health and Preventive Medicine Commons, Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Women's Health Commons
Comments
Trial registration: ClinicalTrials.gov NCT02876640.
Supplementary Materials
PMID: 36228112